Search results
US FTC to sue drug middlemen over insulin prices, source says - ET HealthWorld
The Economic Times· 3 days agoLondon: The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over...
A London biotech raises $114M to hone a new ADC payload
BioPharma Dive· 6 days agoBut, while having conversations with investors, the company pivoted to consider NMTi inhibitors as...
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds - ET...
The Economic Times· 4 days agoThe analysis does not include details about why patients quit. Evidence that many people may stop...
Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
Clinical Trials Arena· 4 days agoFollowing the announcement, Amylyx’s stock took an initial hit before climbing dramatically,...
‘Compounded’ weight-loss drugs are a growing problem for state regulators
Washington State Standard· 5 days agoAnna Wysock’s “aha” moment arrived in an Ohio amusement park, as she got ready to ride a roller...
Longeveron scores RMAT designation for Alzheimer’s cell therapy
Pharmaceutical Technology· 4 days agoThe therapy also improved cognitive functions and reduced neuroinflammation assessed by diffusion...
Impact of AI on metabolic disorder clinical trials
Clinical Trials Arena· 3 days agoMore clinical trials in metabolic research should be expected, especially since pharma giants have entered partnerships with AI companies. For example, ...
'Compounded' weight-loss drugs are a growing problem for state regulators
Stateline.org· 6 days agoJul. 8—Anna Wysock's "aha" moment arrived in an Ohio amusement park, as she got ready to ride a roller coaster with her 7-year-old son: The safety bar across her lap would only click into place ...
Amylyx, with GLP-1 buy, doubles down on blood sugar drugs
BioPharma Dive· 4 days agoHaving recently withdrawn its only product from the market, Amylyx hopes to rebound with a drug that...
India set to witness obesity pill revolution? As patents near expiry, pharma giants gear up for...
Financial Express· 6 days agoBlockbuster obesity drugs like Ozempic and Wegovy have become a global sensation. Now the Indian...